Cargando…

A new validated screening method for endometriosis diagnosis based on patient questionnaires

BACKGROUND: The time between symptoms onset and endometriosis diagnosis is usually long. The negative impacts of delayed endometriosis diagnosis can affect patients and health outcomes. METHODS: We conducted a case-control study using clinical symptoms and epidemiological data extracted from a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapron, Charles, Lafay-Pillet, Marie-Christine, Santulli, Pietro, Bourdon, Mathilde, Maignien, Chloé, Gaudet-Chardonnet, Antoine, Maitrot-Mantelet, Lorraine, Borghese, Bruno, Marcellin, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760436/
https://www.ncbi.nlm.nih.gov/pubmed/35059616
http://dx.doi.org/10.1016/j.eclinm.2021.101263
_version_ 1784633320073592832
author Chapron, Charles
Lafay-Pillet, Marie-Christine
Santulli, Pietro
Bourdon, Mathilde
Maignien, Chloé
Gaudet-Chardonnet, Antoine
Maitrot-Mantelet, Lorraine
Borghese, Bruno
Marcellin, Louis
author_facet Chapron, Charles
Lafay-Pillet, Marie-Christine
Santulli, Pietro
Bourdon, Mathilde
Maignien, Chloé
Gaudet-Chardonnet, Antoine
Maitrot-Mantelet, Lorraine
Borghese, Bruno
Marcellin, Louis
author_sort Chapron, Charles
collection PubMed
description BACKGROUND: The time between symptoms onset and endometriosis diagnosis is usually long. The negative impacts of delayed endometriosis diagnosis can affect patients and health outcomes. METHODS: We conducted a case-control study using clinical symptoms and epidemiological data extracted from a prospective pre-operative patient questionnaire compared between patients with histologically proven endometriosis and patients with no endometriosis at surgical exploration from 2005 to 2018, in a French referral center. We used the beta coefficients of the significant variables introduced in a multiple regression model to devise a score (score 1), evaluated by the area under the curve (or C-index), with three levels, defined by a score between 1 and ≥ 25: (i) highly specific, identifying correctly the patients without the disease; (ii) highly sensitive, identifying the patients with the disease; and (iii) a level maximizing sensitivity and specificity for the best classification of the whole population. To minimize patient self-evaluation of pain, we devised a second score (score 2) with the same method and levels and scores definition, excluding visual analog scale pain scores, except for dysmenorrhea. These scores were validated on an internal and external population. FINDINGS: Score 1 had a C-index of 0.81 (95% CI [0.79–0.83]). Results for the three score 1 levels were: ≥ 25: specificity of 91% (95% CI [89–93]); < 11: sensitivity of 91% (95% CI [89–93]); ≥ 18: specificity of 75% (95% CI [72–78]) and sensitivity of 73% (95% CI [70–76]). Score 2 had a C-index of 0.75 (95% CI [73–77]). The three levels of score 2 were: ≥ 24: specificity of 82% (95% CI [80–85]); < 7: sensitivity of 92% (95% CI [90–94]); ≥ 17: specificity of 62% (95% CI [58–65]) and sensitivity of 78% (95% CI [75–81]). The two scores were internally and externally validated. INTERPRETATION: A score based only on a patient questionnaire could allow identification of a population at high risk of endometriosis. This strategy might help referral to specialized radiologists for a non-surgical endometriosis scan. FUNDING: None.
format Online
Article
Text
id pubmed-8760436
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87604362022-01-19 A new validated screening method for endometriosis diagnosis based on patient questionnaires Chapron, Charles Lafay-Pillet, Marie-Christine Santulli, Pietro Bourdon, Mathilde Maignien, Chloé Gaudet-Chardonnet, Antoine Maitrot-Mantelet, Lorraine Borghese, Bruno Marcellin, Louis EClinicalMedicine Article BACKGROUND: The time between symptoms onset and endometriosis diagnosis is usually long. The negative impacts of delayed endometriosis diagnosis can affect patients and health outcomes. METHODS: We conducted a case-control study using clinical symptoms and epidemiological data extracted from a prospective pre-operative patient questionnaire compared between patients with histologically proven endometriosis and patients with no endometriosis at surgical exploration from 2005 to 2018, in a French referral center. We used the beta coefficients of the significant variables introduced in a multiple regression model to devise a score (score 1), evaluated by the area under the curve (or C-index), with three levels, defined by a score between 1 and ≥ 25: (i) highly specific, identifying correctly the patients without the disease; (ii) highly sensitive, identifying the patients with the disease; and (iii) a level maximizing sensitivity and specificity for the best classification of the whole population. To minimize patient self-evaluation of pain, we devised a second score (score 2) with the same method and levels and scores definition, excluding visual analog scale pain scores, except for dysmenorrhea. These scores were validated on an internal and external population. FINDINGS: Score 1 had a C-index of 0.81 (95% CI [0.79–0.83]). Results for the three score 1 levels were: ≥ 25: specificity of 91% (95% CI [89–93]); < 11: sensitivity of 91% (95% CI [89–93]); ≥ 18: specificity of 75% (95% CI [72–78]) and sensitivity of 73% (95% CI [70–76]). Score 2 had a C-index of 0.75 (95% CI [73–77]). The three levels of score 2 were: ≥ 24: specificity of 82% (95% CI [80–85]); < 7: sensitivity of 92% (95% CI [90–94]); ≥ 17: specificity of 62% (95% CI [58–65]) and sensitivity of 78% (95% CI [75–81]). The two scores were internally and externally validated. INTERPRETATION: A score based only on a patient questionnaire could allow identification of a population at high risk of endometriosis. This strategy might help referral to specialized radiologists for a non-surgical endometriosis scan. FUNDING: None. Elsevier 2022-01-10 /pmc/articles/PMC8760436/ /pubmed/35059616 http://dx.doi.org/10.1016/j.eclinm.2021.101263 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chapron, Charles
Lafay-Pillet, Marie-Christine
Santulli, Pietro
Bourdon, Mathilde
Maignien, Chloé
Gaudet-Chardonnet, Antoine
Maitrot-Mantelet, Lorraine
Borghese, Bruno
Marcellin, Louis
A new validated screening method for endometriosis diagnosis based on patient questionnaires
title A new validated screening method for endometriosis diagnosis based on patient questionnaires
title_full A new validated screening method for endometriosis diagnosis based on patient questionnaires
title_fullStr A new validated screening method for endometriosis diagnosis based on patient questionnaires
title_full_unstemmed A new validated screening method for endometriosis diagnosis based on patient questionnaires
title_short A new validated screening method for endometriosis diagnosis based on patient questionnaires
title_sort new validated screening method for endometriosis diagnosis based on patient questionnaires
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760436/
https://www.ncbi.nlm.nih.gov/pubmed/35059616
http://dx.doi.org/10.1016/j.eclinm.2021.101263
work_keys_str_mv AT chaproncharles anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT lafaypilletmariechristine anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT santullipietro anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT bourdonmathilde anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT maignienchloe anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT gaudetchardonnetantoine anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT maitrotmanteletlorraine anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT borghesebruno anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT marcellinlouis anewvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT chaproncharles newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT lafaypilletmariechristine newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT santullipietro newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT bourdonmathilde newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT maignienchloe newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT gaudetchardonnetantoine newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT maitrotmanteletlorraine newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT borghesebruno newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires
AT marcellinlouis newvalidatedscreeningmethodforendometriosisdiagnosisbasedonpatientquestionnaires